HPWM
CELG

Highland Private Wealth Management’s Celgene Corp CELG Stock Holding History

Highland Private Wealth Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,215
Closed -$220K – 137
2019
Q3 		$220K Buy
2,215
+23
+1% +$2.19K 0.06% 106
2019
Q2 		$202K Buy
+2,192
New +$208K 0.06% 123
2018
Q1 		– Sell
-2,182
Closed -$228K – 171
2017
Q4 		$228K Sell
2,182
-370
-14% -$41.7K 0.09% 86
2017
Q3 		$372K Buy
2,552
+5
+0.2% +$681 0.16% 55
2017
Q2 		$331K Buy
2,547
+6
+0.2% +$735 0.16% 56
2017
Q1 		$316K Buy
2,541
+167
+7% +$20K 0.16% 52
2016
Q4 		$275K Buy
2,374
+435
+22% +$48.4K 0.14% 57
2016
Q3 		$203K Buy
+1,939
New +$210K 0.1% 75

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Highland Private Wealth Management's CELG Position: Q4 2019 in Review

Highland Private Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,215 shares — an estimated $220K sold.

Highland Private Wealth Management first reported a position in CELG in Q3 2016 and held it in 8 quarters. The position peaked at $372K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Highland Private Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Highland Private Wealth Management sold 2,215 Celgene Corp shares in Q4 2019, an estimated $220K.
  • Highland Private Wealth Management first reported a position in Celgene Corp in Q3 2016 and held it in 8 quarters.
  • Highland Private Wealth Management's Celgene Corp position peaked at $372K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Highland Private Wealth Management's 13F filing for Q4 2019, filed 10 Feb 2020.